We only market innovative, high-quality products. Period.

Over the years, we have built a portfolio of exclusively licensed human medicines and medical devices. Our vision is to build strong, sustainable brands in our markets which requires such exclusivity with our partners for their originator products. A select list of proprietary oligonucleotides for research purposes was developed for our sister company Effimed Research and these are also sold to external customers.

Please contact our business development team if you would like to discuss how your product could fit in our strategy. If you are a distributor or HCP interested in distribution or sales for our products, please sign-up on the contact page.

Our global portfolio includes 48 products in major therapeutic categories:

• Aesthetics & Dermatology
• Endocrinology
• Pain
• Rare Diseases
• Research & Lab Supplies

Fillers

Aesthetic hyaluronic acid fillers. Multiple strength and applications for refinement, volume, and fullness.

Biorevitalizers

Injectable solutions for skin defects and rejuvenation.

Toxins

The world's first next-generation vegan botulinum toxin for skin smoothness and radiance.

Anti-fungals

Topical treatments for skin and nails.

HRT

Innovative Hormone Replacement Therapies for men and women.

Acute Pain

Chronic Pain

Non-opioid topical and systemic therapies.

Rare Diseases

Our team has been involved in bringing first-in-class drugs to market for rare diseases. We strive to make them available to more patients in less developed countries around the world.

Peptides

Bioactive oligonucleotides for research applications.